More than 100 next generation RNA therapeutics and vaccines are being developed to offer an advanced, low-dose form of treatment, targeting a wide range of therapeutic indications
The traditional RNA-based therapies are known to be associated with various stability and delivery-related challenges. This has prompted industry stakeholders to modify such therapies to develop next generation therapies with enhanced stability and self-replicating capability. Further, the development of novel technologies for the development and delivery of such therapies has escalated the interest of industry stakeholders in enhanced and modified RNA-based therapies. The next generation RNA therapies domain is anticipated to evolve rapidly to become the next big therapeutic segment in the coming decade.
- The financial opportunity associated with RNA Therapeutics and RNA Vaccines Market has been analyzed across the following segments:
- Type of Modality
- Therapeutics
- Vaccines
- Type of Molecule
- Replicating RNA (repRNA)
- Self amplifying RNA (saRNA)
- Self activating RNA (sacRNA)
- Self activating mRNA (sa-mRNA)
- Transfer RNA (tRNA)
- Therapeutic Area
- Infectious Diseases
- Oncological Disorders
- Pulmonary Disorders
- Route of Administration
- Intradermal
- Intramuscular
- Intravenous
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Leading Industry Players
- Alphavax
- Company 1
- Company 2
- Company 3
The RNA Therapeutics and RNA Vaccines Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
- Alphavax
- Arcturus Therapeutics
- Atyr Pharma
- Gritstone Bio
- HDT Bio
- MiNA Therapeutics
- VLP Therapeutics
Table of Contents
- PREFACE
- RESEARCH METHODOLOGY
- ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
- EXECUTIVE SUMMARY
- INTRODUCTION
- MARKET LANDSCAPE
- TECHNOLOGY LANDSCAPE
- DRUG PROFILES
- CLINICAL TRIAL ANALYSIS
- PATENT ANALYSIS
- PARTNERSHIPS AND COLLABORATIONS
- FUNDING AND INVESTMENT ANALYSIS
- BIG PHARMA INITIATIVES
- OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, 2023-2035
- OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY TYPE OF MODALITY
- OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY TYPE OF MOLECULE
- OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY THERAPEUTIC AREA
- OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY ROUTE OF ADMINISTRATION
- OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY KEY GEOGRAPHICAL REGIONS
- OVERALL RNA THERAPEUTICS AND RNA VACCINES MARKET, BY LEADING PLAYERS
- CONCLUSION
- APPENDIX 1: TABULATED DATA
- APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/rna-therapeutics-market.html
News article
Antibody Drug Conjugate Market
Learn from experts: do you know about these emerging industry trends?
Transformation of Biopharmaceuticals Manufacturing Through Single-use Bioreactors
Liposome: A Novel Drug Delivery System
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415